SKIP TO CONTENT
About Abbott
Contact
International | eng
Country Language
International | eng
Country Language

Coronary Physiology Products

Go Beyond the Angiogram with Abbott's Coronary Physiology Portfolio

Physiological measurements such as fractional flow reserve (FFR) and resting full-cycle ratio (RFR) can be used to evaluate the functional significance of coronary stenosis. 1,2

Beyond the visibility of angiography, index of microcirculatory resistance (IMR) and coronary flow reserve (CFR) can be used to diagnose coronary microvascular dysfunction.3,4

A comprehensive physiology assessment can improve PCI outcomes and patients quality of life.3, 5-6

PressureWire™ X Guidewire

The innovative PressureWire™ X Guidewire—the world’s only wireless physiology wire1,3,7—can measure pressure and temperature to calculate Abbott's RFR, FFR, IMR, and CFR. The guidewire’s fully integrated, secure, wireless measurements are integral to a cardiac cath lab’s clinical physiology routine.1

View Product
PressureWire™ X Guidewire

Coroventis‡ CoroFlow‡ Cardiovascular System

Used with the PressureWire™ X Guidewire, the Coroventis‡ CoroFlow‡ Cardiovascular System is an advanced platform to measure comprehensive physiological indices: FFR, RFR, IMR, and CFR.8

View Product
Coroventis CoroFlow Cardiovascular System

QUANTIEN™ Measurement System

The QUANTIEN™ Measurement System, with its wireless design, frees the cardiac cath lab from cables. The QUANTIEN™ Measurement System offers users full integration without time-consuming setup or lab downtime.9

View Product
QUANTIEN™ Measurement System

OPTIS™ Imaging Systems

The OPTIS™ Imaging Systems offers wireless physiology (FFR and RFR) and optical coherence tomography (OCT) with seamless integration into the cath lab and PCI workflow.10

View Product
OPTIS™ Imaging Systems

ULTREON™ 1.0 Software

Ultreon™ 1.0 Software is the next-generation imaging and physiology software. Streamlined and intuitive, Ultreon™ Software gives better insights to optimize patient outcomes through automation and improved workflow.11-14

View Product
ULTREON™ 1.0 Software

Learn More About Comprehensive Physiology Indices to Assess the Entire Coronary Vasculature

View Physiology Indices

Abbott's Legacy of Leadership in Coronary Physiology

As a leader in PCI, Abbott also has a rich legacy of supporting research, developing products and advancing technology related to coronary physiology. Abbott’s accomplishments offer interventional cardiologists key data as well as cutting-edge technology.

Abbott's Legacy of Leadership
Manuals & Resources

Manuals & Resources

Customer Service

Customer Service

References

  1. PressureWire™ X IFU
  2. Svanerud J, et al. Validation of a novel non-hyperaemic index of coronary artery stenosis severity: the Resting Full-cycle Ratio (VALIDATE RFR) study. EuroIntervention. 2018;14:806-814.
  3. Ford T, et al. CorMicA Trial. 2018; 72(23): 2841-55 with online appendix.
  4. Kunadian V, Chieffo A et al. EHJ & Eurointervention 2020: ehaa503. DOI:10.1093/eurheartj/ehaa503.
  5. Tonino PA, et al. Angiographics versus functional severity of coronary artery stenoses in the FAME study: Fractional flow reserve versus angiography in multivessel evaluation. J Am Coll Cardiol 2010; 55:2816-21.
  6. De Bruyne B, et al. FFR Guided PCI versus Medical Therapy in Stable Coronary Disease, NEJM. 2012; 367 (11): 991-1001.
  7. Volcano Corp. Verrata‡ guidewire and PrimeWire Prestige‡ Plus guidewire IFUs, Opsens Inc. OptoWire‡ guidewire and OptoWire‡ II guidewire IFUS, ACIST Medical Systems. Navvus‡ Microcatheter IFU, Boston Scientific Corporation. Comet‡ guidewire IFU.
  8. Coroventis‡ CoroFlow‡ Cardiovascular System IFU.
  9. QUANTIEN™ Measurement System IFU.
  10. OPTIS™ Measurement System IFU
  11. Data on file at Abbott.
  12. Zhang J, et al. Intravascular ultrasound versus angiography-guided drug-eluting stent implantation: the ULTIMATE trial. J Am Coll Cardiol. 2018;72(24):3126-3137. doi: 10.1016/j.jacc.2018.09.013.
  13. Hong M, et al. IVUS-XPL 5 Year Outcomes, TCT 2019.
  14. Jones et al. JACC Cardiovascular Interventions, 2018, vol 11 (14). “Angiography Alone Versus Angiography Plus Optical Coherence Tomography to Guide Percutaneous Coronary Intervention – Outcomes From the Pan-London PCI Cohort”.

MAT-2104372 v2.0

POLICIES & ADVISORIES
HEALTHCARE PROFESSIONALS
PATIENTS & CAREGIVERS
Abbott logo

Information contained herein for distribution outside the U.S. only.

CAUTION: These products are intended for use by or under the direction of a physician. Prior to use, reference the Instructions for Use, inside the product carton (when available) or online for more detailed information on Indications, Contraindications, Warnings, Precautions and Adverse Events.

Illustrations are artist's representations only and should not be considered as engineering drawings or photographs.

Unless otherwise specified, all product names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company. ™ Indicates a trademark of the Abbott group of companies. ‡ Indicates a third party trademark, which is property of its respective owner.

© 2023 Abbott. All Rights Reserved.

MAT-2001111 v5.0

Disclaimer

You are about to enter an Abbott country- or region-specific website. 

Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions

Do you wish to continue and enter this website? 

MAT-2305078 v1.0